Clinical Trials Browser

Phase 2/3 × Neoplasms × Methylphenidate × Clear all

NCT05474846 2025-11-06

Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer

Phase 2/3 Recruiting

Anxiety Disorders, Depression, Fatigue, Neoplasms

NCT00758407 2010-01-13

EMF

Phase 2/3 Completed

Fatigue, Neoplasms